Top Ten "Must Attend" Breakout Sessions at the 2011 BIO International Convention

John Sterling’s picks:
TOP TEN “MUST ATTEND” BREAKOUT SESSIONS

74 - Getting Approval for Drugs in an Ever-Increasing Risk-Averse World (Track: Achieving Regulatory Approval and Compliance)
Monday, June 27
2:00 pm - 3:15 pm

• Give insight on the changing regulatory environment and critical success factors for new applications.
• Describe the challenges of a filing process from the company’s and regulator’s point of view.
• Learn how to get a cell therapy product evaluated as a drug.

77 - Talking About Your Product in the New Age: Social Media and the Internet (Track: Achieving Regulatory Approval and Compliance) 
Tuesday, June 28
3:45 pm - 5:00 pm

• Understand current regulatory standards and policies related to dissemination of information outside of labeling.
• Understand current venues for disseminating product information on the Internet and through social media.
• Understand potential liability, and identify measures to avoid it.

90 - Rediscovering the Promise of Biomarkers (Track: Biomarkers) 
Tuesday, June 28
8:30 am - 9:45 am

• Learn about new models for international PPPs to reduce risk and cost for biomarker research.
• Understand the regulatory challenges facing the biomarkers qualification and validation.
• Explore how to work internationally to leverage resources for biomarker research.

198 - Crossing the Financing Gap? Alternative Strategies for Funding Biomedical Technologies for the Clinic (Track: Finance) 
Monday, June 27
2:00 pm - 3:15 pm

• Describe innovative strategies that leverage alternative sources of capital to enable development.
• Discuss current financing for clinically related biotechnologies, including nontraditional sources.
• Discover nondilutive NIH funding opportunities and resources that support early development.

98 - Personalized Medicine and Companion Diagnostics: The Changing Biopharma Industry Landscape (Track: Diagnostics and Personalized Medicine) 
Thursday, June 30
8:30 am - 9:45 am

• Develop an understanding of the personalized medicine landscape.
• Interact with thought leaders in the industry.
• Give audience the opportunity to follow up for potential collaborative initiatives.

174 - The Effect of a More Risk Averse Environment on Licensing Deals (Track: Business Development) 
Monday, June 27
2:00 pm - 3:15 pm

• Describe the current environment within licensing biopharma companies with regard to risk for in-licensed programs.
• Indicate specific risk management strategies and their implications.
• Give advice from licensees on how best to strategize with a licensing partner.

188 - The Changing BD Environment: Overcoming Our Past to Succeed in the Future (Track: Business Development) 
Tuesday, June 28
2:00 pm - 3:30 pm